Is CBN legal in the Netherlands?

Formal status

CBN is classified as a Novel Food across the EU on the same basis as CBD - hemp extracts concentrated in cannabinoids fall within Regulation (EU) 2015/2283 - and no CBN ingestible holds Union list authorisation anywhere in the EU.

CBN as a molecule is not scheduled under the Opiumwet, and no Dutch instrument, guidance or reported case addressing CBN specifically was located. On its own terms CBN is unregulated in the Netherlands.

That does not help the product, and the reason is worth stating precisely. The Dutch constraint attaches to hennepolie - concentrate of plants of the genus Cannabis obtained by extraction of hemp or hashish. That definition operates on the extraction process, not on which cannabinoid the extraction yields, so it does not distinguish CBN from CBD at all. A CBN-bearing full-spectrum extract sits inside it on identical terms, and Articles 2 and 3 of the Opiumwet name importing, delivering, supplying and transporting among the prohibited acts, with criminal penalties.

As with CBD, we were not able to read the current schedule text ourselves to confirm the entry stands in its present form, and we say so rather than assert it.

Do we sell here?

No.

We don't sell to the Netherlands.

The Netherlands has never published a position on CBN specifically - it is not a controlled substance there, and Dutch guidance does not mention it. We are not treating that silence as permission, because it is not what decides the question.

What decides it is that Dutch drug law treats hemp extract itself as a controlled substance, defined by the fact of extraction rather than by which cannabinoid comes out of it. That wording does not distinguish CBN from CBD. Our capsules and spray are made from a full-spectrum extract, so on the ordinary reading of the Dutch rule the whole product is caught whatever CBN's own status.

We explain the position and its uncertainties in full on our CBD page for the Netherlands. Our 1 mg of melatonin is a separate and independent problem there, set out on the melatonin page.

Outlook

Because the Dutch constraint is drafted around the extraction process rather than around a named cannabinoid, a CBN-forward reformulation gains nothing here. Neither would an EU-level Novel Food authorisation for CBD, which would leave the narcotics question untouched.

The development that matters is the same one that matters for CBD: the questions referred to the Court of Justice of the EU in February 2026 on whether Union law permits the Netherlands to criminalise the import from another member state of low-THC hemp grown from certified seed. A first Dutch statement naming CBN would be a genuine new datapoint, but on the current mechanism it would not change the outcome.

Timeline

February 2017

Gerechtshof Den Haag convicts a Rotterdam operator in respect of EU-certified industrial fibre hemp, below 0.2 per cent THC and held with certification, intended for the production of CBD oil. The prosecution relied on the Opiumwet definition of hennepolie - concentrate of plants of the genus Cannabis obtained by extraction of hemp or hashish, whether or not mixed with oil - to treat hemp extract material as a controlled substance. Defence commentary criticises the court for holding that cultivating and processing fibre hemp is lawful while possessing it is not.

CNNBS, reporting Gerechtshof Den Haag

February 2026

The Hoge Raad refers questions to the Court of Justice of the EU on whether it is compatible with Union law to criminalise, under the Opiumwet, the possession and the import from another member state of hemp grown from certified seed and/or with a THC content no higher than 0.3 per cent. The referral puts the application of the Dutch narcotics framework to low-THC hemp lawfully produced elsewhere in the EU directly in issue.

Hoge Raad der Nederlanden